Fifteen students in the MD-PhD program at the Jacobs School of Medicine and Biomedical Sciences presented posters at the Tri-Institutional MD-PhD Research Day last fall at the Jacobs School building in downtown Buffalo.
A UB spinoff company that is developing a low-cost blood test to screen high-risk patients for unruptured brain aneurysms has received $750,000 Phase II Small Business Innovation Research (SBIR) funding from the National Science Foundation (NSF).
Eight faculty members from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 16th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.
Twenty-five faculty members with a variety of clinical and research experience — representing eight medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.
The University at Buffalo has officially launched the UB Biorepository, a critical new facility in the Clinical and Translational Research Center that will serve as a powerful resource in driving biomedical innovation in academia and industry regionally and throughout the state.
Atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which patients will progress to the most severe form of multiple sclerosis (MS), according to a retrospective, five-year study of 1,314 MS patients.
Twenty-two faculty members with a variety of clinical and research experience — representing nine medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.
An innovative researcher and others who have made significant contributions to their fields and to the Jacobs School of Medicine and Biomedical Sciences were honored with 2019 Faculty-Staff Recognition Awards.